NCT00091637Phase 3Completed

Pexelizumab in Conjunction With Angioplasty in Acute Myocardial Infarction (APEX-AMI)

Study sponsor: Procter and Gamble

Primary completion is the date data collection ends for the main study measures, not when results are published.

Primary completion2007-05Actual
Enrollment · participants5745Actual
Source updated2023-11-18Last update listed in the registry record

Changes to this trial

Last 12 months
Filters
Clear filters
No recorded changes are available for this view and time period. Our history may be incomplete; this does not establish that the trial stayed unchanged.